NCT04189588 2023-10-06
versus
TerSera Therapeutics LLC
Phase 2 Completed
Clinical Trials
4 trialsNCT01549886 2021-10-04
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc
Phase 2 Terminated
NCT00220285 2014-12-30
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
Bayer
Phase 2 Completed
NCT00505232 2012-01-02
LCM-04-02
CABYC
Phase 2 Completed